Brief: Ligand Pharmaceuticals Is Buying Xoma For Nearly $740 Million - WSJ
27/04/2026 11:18
April 27 (Reuters) - LIGAND PHARMACEUTICALS IS BUYING XOMA FOR NEARLY $740 MILLION - WSJ LIGAND PHARMACEUTICALS' DEAL FOR XOMA WOULD VALUE XOMA AT $39 A SHARE - WSJ Source text: https://tinyurl.com/2pcc9x4r Further company coverage: LGND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan